Everyone is an expert with hindsight Twin, and your extensive research efforts are a major reason for me, and I am sure others, not heading for the door on ADO.
As with any stock, it is delivery that will be the LT determinant of sentiment and SP, and as with many Bio sector stocks time is never kind.
I agree that 2013 will be a watershed year for ADO, either way, as prudent directors or actual sales growth will determine in which direction we travel.
I guess my one concern is that with Big Bio able to take its time it will be important that ADO never allows the suggestion of time running out to enter into the equation.
Ann: 2012 Annual Report , page-17
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $7.817K | 372.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 192257 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 944185 | 6 |
View Market Depth
| Last trade - 15.43pm 20/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |